The Impact of Bigness in the Life Sciences: A View from Windhover's Start-Up Symposium
This article was originally published in Start Up
Executive Summary
Bigness is pervading the life sciences. Larger investments and larger partners are driving start-ups toward the largest markets to get ROI, encouraging in-licensing and rollup strategies. In devices, the trend towards size comes at the expense of developing niche markets. Meanwhile, biotechs are realizing they must integrate more and more technologies in parallel to get a complete biological picture of disease.